Podoplanin-positive carcinoma-associated fibroblasts drive progression and metastatic potential of head and neck squamous cell carcinoma
平足蛋白阳性癌相关成纤维细胞驱动头颈鳞状细胞癌的进展和转移潜力
基本信息
- 批准号:9395731
- 负责人:
- 金额:$ 3.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-06-01 至 2017-12-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAntibodiesC57BL/6 MouseCarcinomaCell LineCell SurvivalCellsCessation of lifeComplementControl AnimalCorrelative StudyDataDiagnosisDiseaseDisease ProgressionDistantExposure toExtracapsularFaceFibroblastsGenetic EngineeringGlycoproteinsGoalsHarvestHead and Neck Squamous Cell CarcinomaHeartHumanImmuneImmunosuppressionImmunosuppressive AgentsIn VitroInfiltrationInjectableInjection of therapeutic agentInvadedLungLymph Node TissueLymphangiogenesisLymphaticLymphatic SystemMalignant Epithelial CellMalignant NeoplasmsMediatingMetastatic Neoplasm to Lymph NodesMolecularMusNeoplasm MetastasisNitric OxideNude MiceOutcomePatientsPlayPrimary NeoplasmProcessProteinsRegulationRoleSeedsSeveritiesSignal TransductionSignaling ProteinSiteSublingual RegionSurvival RateSystems DevelopmentT-LymphocyteTherapeuticTimeTissuesTongueTransplantationTumor BurdenTumor TissueUnited Statesadvanced diseasecancer cellcancer typecell motilitycell typedensityimmunosuppressedimprovedin vivoinsightinterestknock-downlymph nodesmetastatic processmigrationmortalityneoplastic celloutcome forecastpermissivenesspodoplaninsmall hairpin RNAtumortumor microenvironmenttumor progression
项目摘要
Project Summary/Abstract:
Head and neck squamous cell carcinoma is the sixth most common malignancy worldwide. Metastasis reduces survival
rates for patients to only 37%, indicating the severity of advanced disease, but there remains much to be understood about
the metastatic process. Emerging evidence suggests the tumor microenvironment contributes to HNSCC progression and
this proposal aims to clarify the role of one microenvironment cell type, carcinoma-associated fibroblasts (CAFs).
HNSCC has a high propensity for metastasis to the lymph nodes, and correlative studies have indicated high expression of
the transmembrane glycoprotein podoplanin (PDPN) is indicative of poor patient prognosis. It has been suggested that
CAFs may be expressing PDPN in the lymph nodes, though this has yet to be determined. In addition, PDPN+ CAFs in
other cancer types have been shown to have varying roles in either promoting or inhibiting cancer progression though
little data exists for HNSCC. This project will expand upon my preliminary data indicating CAFs from both the primary
tumor and tumor-associated lymph nodes are, indeed, PDPN+ and accelerate HNSCC migration in vitro. The overarching
objectives are to identify the mechanism of PDPN+ CAFs in facilitating HNSCC invasive and migratory potential, as
metrics of metastatic potential, as well as assess the ability of the PDPN+ CAFs to enhance lymphangiogenesis and to seed
a pre-metastatic, immunosuppressed, tumor-supportive niche in the lymph nodes. In vitro analyses will investigate the
PDPN-dependent secreted factors that may influence HNSCC progression as well as downstream signaling of PDPN
within the CAFs that may result in increased cell contractility and immunosuppressive abilities. All in vitro data will be
complemented by mouse studies in the presence and absence of PDPN expression with outcomes analyzing lymphatic
vasculature density, lymph node immune infiltration, and overall metastatic tumor burden. Study findings are expected to
identify PDPN and/or its effectors as (a) potential target(s) for the treatment of metastatic HNSCC in an effort to reduce
mortality rates caused by the devastation of metastatic occurrence.
项目概要/摘要:
头颈部鳞状细胞癌是全球第六大常见恶性肿瘤。转移降低生存率
患者的发病率仅为37%,表明晚期疾病的严重程度,但仍有许多问题需要了解。
转移过程。新出现的证据表明肿瘤微环境有助于HNSCC进展,
该建议旨在阐明一种微环境细胞类型,癌相关成纤维细胞(CAF)的作用。
HNSCC具有向淋巴结转移的高倾向,相关研究表明HNSCC高表达,
跨膜糖蛋白podoplanin(PDPN)是患者预后差的指示。有人建议
CAF可能在淋巴结中表达PDPN,但这尚未确定。此外,PDPN+ CAF
其他癌症类型在促进或抑制癌症进展方面具有不同的作用,
HNSCC的数据很少。这个项目将扩大我的初步数据表明CAF从两个主要的
肿瘤和肿瘤相关淋巴结确实是PDPN+,并加速HNSCC的体外迁移。总体
目的是确定PDPN+ CAF促进HNSCC侵袭和迁移潜力的机制,
转移潜力的指标,以及评估PDPN+ CAF增强淋巴管生成和接种的能力。
淋巴结中的转移前、免疫抑制、肿瘤支持性小生境。体外分析将研究
可能影响HNSCC进展以及PDPN下游信号传导的PDPN依赖性分泌因子
在CAF内,这可能导致细胞收缩性和免疫抑制能力增加。所有体外数据将
在存在和不存在PDPN表达的情况下进行小鼠研究,结果分析淋巴结
脉管系统密度、淋巴结免疫浸润和总体转移性肿瘤负荷。研究结果预计将
鉴定PDPN和/或其效应物作为治疗转移性HNSCC的潜在靶标,以努力减少
死亡率由转移发生的破坏引起。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kelsey J Weigel其他文献
Kelsey J Weigel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 3.68万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 3.68万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 3.68万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 3.68万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 3.68万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 3.68万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 3.68万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 3.68万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 3.68万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 3.68万 - 项目类别: